A multicentre randomiSed controlled TRial of Intravenous immunoglobulin (IVIg) versus standard therapy for the treatment of transverse myelitis in adults and children
Phase of Trial: Phase III
Latest Information Update: 24 Oct 2017
At a glance
- Drugs Immunoglobulin G (Primary) ; Methylprednisolone
- Indications Myelitis
- Focus Therapeutic Use
- Acronyms STRIVE
- 11 May 2017 This trial has been completed in the United Kingdom (end date: 11 May 2016).
- 18 Jul 2016 Status changed from completed to discontinued.
- 12 Jul 2016 Status changed from active, no longer recruiting to completed.